CRMD (Cormedix) Net Interest Margin (Bank Only) %


CRMD Cormedix Inc CRMD
43 GF Score
Price $8.74
GF Value $66.12
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Cormedix Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

CRMD
43GF Score
Cormedix Inc CRMD
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cormedix (CRMD) Overvalued in 2026?

Based on GuruFocus' analysis, Cormedix stock appears to be undervalued. The current stock price of $8.74 is trading 86.8% below its estimated GF Value™ of $66.12. GuruFocus considers Cormedix to be Possible Value Trap.

Key valuation signals for CRMD:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: $66.12 vs. price of $8.74 (86.8% below fair value)
  • GF Score™: 43/100 with 6 warning signs

No single metric tells the full story. See the CRMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cormedix Business Description

Other Exchanges 19KA:Germany
Address 389 Interpace Parkway, Suite 450, Parsippany, NJ, USA, 07054
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
43GF Score

Get the complete analysis for CRMD

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.74
Price
$66.12
GF Value